🇺🇸 FDA
Patent

US 7915385

Sodium channel protein type III α-subunit splice variant

granted A61PA61P1/00A61P11/06

Quick answer

US patent 7915385 (Sodium channel protein type III α-subunit splice variant) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P1/00, A61P11/06, A61P25/00, A61P25/18